Involvement of the Retinoid X Receptor Ligand in the Anti-Inflammatory Effect Induced by Peroxisome Proliferator-Activated Receptor γ Agonist In Vivo

被引:15
|
作者
Yamamoto, Atsuki [1 ]
Kakuta, Hiroki [1 ]
Miyachi, Hiroyuki [1 ]
Sugimoto, Yukio [1 ]
机构
[1] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Kita Ku, Okayama 7008530, Japan
关键词
NECROSIS-FACTOR-ALPHA; PPAR-GAMMA; NITRIC-OXIDE; DOWN-REGULATION; RXR AGONISTS; PAW EDEMA; CELLS; INFLAMMATION; HETERODIMERS; EXPRESSION;
D O I
10.1155/2011/840194
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Peroxisome proliferator-activated receptor gamma (PPAR gamma) forms a heterodimeric DNA-binding complex with retinoid X receptors (RXRs). It has been reported that the effect of the PPAR agonist is reduced in hepatocyte RXR-deficient mice. Therefore, it is suggested that the endogenous RXR ligand is involved in the PPAR gamma agonist-induced anti-inflammatory effect. However, the participation of the RXR ligand in the PPAR gamma-induced anti-inflammatory effect is unknown. Here, we investigated the influence of RXR antagonist on the anti-inflammatory effect of PPAR gamma agonist pioglitazone in carrageenan test. In addition, we also examined the influence of PPAR antagonist on the anti-inflammatory effect induced by RXR agonist NEt-3IP. The RXR antagonist suppressed the antiedema effect of PPAR gamma agonist. In addition, the anti-inflammatory effect of RXR agonist was suppressed by PPAR gamma antagonist. PPAR gamma agonist-induced anti-inflammatory effects were reversed by the RXR antagonist. Thus, we showed that the endogenous RXR ligand might contribute to the PPAR gamma agonist-induced anti-inflammatory effect.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] Retinoid X receptor and peroxisome proliferator-activated receptor activate an estrogen responsive gene independent of the estrogen receptor
    Nunez, SB
    Medin, JA
    Braissant, O
    Kemp, L
    Wahli, W
    Ozato, K
    Segars, JH
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1997, 127 (01) : 27 - 40
  • [32] Curcumin is not a ligand for peroxisome proliferator-activated receptor-γ
    Narala, Venkata R.
    Smith, Monica R.
    Adapala, Ravi K.
    Ranga, Rajesh
    Panati, Kalpana
    Moore, Bethany B.
    Leff, Todd
    Reddy, Vudem D.
    Kondapi, Anand K.
    Reddy, Raju C.
    GENE THERAPY AND MOLECULAR BIOLOGY, 2009, 13 (01): : 20 - 25
  • [33] Ligand-induced stabilization and activation of peroxisome proliferator-activated receptor γ
    Gani, Osman A. B. S. M.
    Sylte, Ingebrigt
    CHEMICAL BIOLOGY & DRUG DESIGN, 2008, 72 (01) : 50 - 57
  • [35] Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor gamma and the retinoid X receptor
    Tontonoz, P
    Singer, S
    Forman, BM
    Sarraf, P
    Fletcher, JA
    Fletcher, CDM
    Brun, RP
    Mueller, E
    Altiok, S
    Oppenheim, H
    Evans, RM
    Spiegelman, BM
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (01) : 237 - 241
  • [36] PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-α MODULATES THE ANTI-INFLAMMATORY EFFECT OF GLUCOCORTICOIDS IN A MODEL OF INFLAMMATORY BOWEL DISEASE IN MICE
    Riccardi, Luisa
    Mazzon, Emanuela
    Bruscoli, Stefano
    Esposito, Emanuela
    Crisafulli, Concetta
    Di Paola, Rosanna
    Caminiti, Rocco
    Riccardi, Carlo
    Cuzzocrea, Salvatore
    SHOCK, 2009, 31 (03): : 308 - 316
  • [37] Peroxisome proliferator-activated receptor γ and retinoid X receptor ligands are potent inducers of differentiation and apoptosis in leukemias
    Konopleva, M
    Elstner, E
    McQueen, TJ
    Tsao, T
    Sudarikov, A
    Hu, W
    Schober, WD
    Wang, RY
    Chism, D
    Kornblau, SM
    Younes, A
    Collins, SJ
    Koeffler, HP
    Andreeff, M
    MOLECULAR CANCER THERAPEUTICS, 2004, 3 (10) : 1249 - 1262
  • [38] Anti-inflammatory actions of peroxisome proliferator-activated receptor gamma agonists in Alzheimer's disease
    Landreth, GE
    Heneka, MT
    NEUROBIOLOGY OF AGING, 2001, 22 (06) : 937 - 944
  • [39] Protective effect of nonsteroidal anti-inflammatory drugs on colorectal adenomas is modified by a polymorphism in peroxisome proliferator-activated receptor δ
    Siezen, CLE
    Tijhuis, MJ
    Kram, NR
    van Soest, EM
    de Jong, DJ
    Fodde, R
    van Kranen, HJ
    Kampman, E
    PHARMACOGENETICS AND GENOMICS, 2006, 16 (01): : 43 - 50
  • [40] Peroxisome proliferator-activated receptor δ confers resistance to peroxisome proliferator-activated receptor γ-induced apoptosis in colorectal cancer cells
    Wang, D.
    Ning, W.
    Xie, D.
    Guo, L.
    DuBois, R. N.
    ONCOGENE, 2012, 31 (08) : 1013 - 1023